These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21444322)

  • 21. Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.
    Becker B; Wagner D; Koester P; Bender K; Kabbasch C; Gouzoulis-Mayfrank E; Daumann J
    Psychopharmacology (Berl); 2013 Feb; 225(4):923-34. PubMed ID: 23001254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal and visual source memory deficits among ecstasy/polydrug users.
    Fisk JE; Gallagher DT; Hadjiefthyvoulou F; Montgomery C
    Hum Psychopharmacol; 2014 Mar; 29(2):172-82. PubMed ID: 24446108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of stereotype threat on cognitive function in ecstasy users.
    Cole JC; Michailidou K; Jerome L; Sumnall HR
    J Psychopharmacol; 2006 Jul; 20(4):518-25. PubMed ID: 16174670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects.
    Jacobsen LK; Mencl WE; Pugh KR; Skudlarski P; Krystal JH
    Psychopharmacology (Berl); 2004 May; 173(3-4):383-90. PubMed ID: 14647960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
    de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
    Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunctional overnight memory consolidation in ecstasy users.
    Smithies V; Broadbear J; Verdejo-Garcia A; Conduit R
    J Psychopharmacol; 2014 Aug; 28(8):751-62. PubMed ID: 24595967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
    Parrott AC; Sisk E; Turner JJ
    Drug Alcohol Depend; 2000 Jul; 60(1):105-10. PubMed ID: 10821995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective memory deficits in illicit polydrug users are associated with the average long-term typical dose of ecstasy typically consumed in a single session.
    Gallagher DT; Hadjiefthyvoulou F; Fisk JE; Montgomery C; Robinson SJ; Judge J
    Neuropsychology; 2014 Jan; 28(1):43-54. PubMed ID: 24015828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.
    Jager G; de Win MM; Vervaeke HK; Schilt T; Kahn RS; van den Brink W; van Ree JM; Ramsey NF
    Psychopharmacology (Berl); 2007 Aug; 193(3):403-14. PubMed ID: 17476480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
    Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M
    Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal remodelling after MDMA neurotoxicity: a single case study.
    Nifosì F; Martinuzzi A; Toffanin T; Costanzo R; Vestri A; Battaglia M; Bertagnoni GE; Lupi A; Amistà P; Carollo C; Perini G
    World J Biol Psychiatry; 2009; 10(4 Pt 3):961-8. PubMed ID: 18609419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.